Timothy Kelly E.'s Insider Trades & SAST Disclosures
Timothy Kelly E.'s most recent trade in Praxis Precision Medicines Inc was a trade of 25,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Timothy Kelly E..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 12,500 | 24,706 | - | 0 | Common Stock | |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.15 per share. | 10 Jan 2025 | 676 | 24,030 | - | 63.1 | 42,689 | Common Stock |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.52 per share. | 07 Jan 2025 | 139 | 12,206 | - | 77.5 | 10,775 | Common Stock |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 37.40 per share. | 14 Nov 2024 | 205 | 12,345 | - | 37.4 | 7,667 | Common Stock |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 36,400 | 36,400 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 7,800 | 12,140 | - | 0 | Common Stock | |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 12.37 per share. | 14 May 2024 | 606 | 4,340 | - | 12.4 | 7,495 | Common Stock |
| Praxis Precision Medicines... | Kelly Timothy E. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Timothy Kelly E. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.19 per share. | 07 Jan 2024 | 139 | 3,734 | - | 25.2 | 3,501 | Common Stock |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.88 per share. | 12 May 2023 | 11,683 | 58,099 | - | 0.9 | 10,328 | Common Stock |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 24 Mar 2023 | 8,000 | 46,416 | - | 0.9 | 6,998 | Common Stock |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 42,455 | 42,455 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.52 per share. | 07 Jan 2023 | 2,079 | 38,416 | - | 2.5 | 5,239 | Common Stock |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.80 per share. | 14 Nov 2022 | 5 | 40,495 | - | 1.8 | 9 | Common Stock |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 09 Jun 2022 | 10,000 | 40,490 | - | 1.8 | 17,650 | Common Stock |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 8.80 per share. | 13 May 2022 | 2,585 | 30,490 | - | 8.8 | 22,743 | Common Stock |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 84,000 | 84,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 24,000 | 27,905 | - | 0 | Common Stock | |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 19.48 per share. | 31 Aug 2021 | 3,905 | 3,905 | - | 19.5 | 76,069 | Common Stock |
| Praxis Precision Medicines... | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges